XML 38 R24.htm IDEA: XBRL DOCUMENT v3.20.2
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
12 Months Ended
Sep. 30, 2020
Quarterly Financial Information Disclosure [Abstract]  
QUARTERLY FINANCIAL INFORMATION (UNAUDITED) QUARTERLY FINANCIAL INFORMATION (UNAUDITED)

Quarterly results of continuing operations for 2020 and 2019 were as follows:
Quarter ended
Revenue
 
Gross Profit
 
Income from continuing operations
 
Per Share -
Basic
 
Per Share -
Diluted
2020
 

 
 

 
 

 
 

 
 

December 31, 2019
$
548,438

 
$
149,921

 
$
10,612

 
$
0.26

 
$
0.24

March 31, 2020
566,350

 
152,032

 
895

 
0.02

 
0.02

June 30, 2020
632,061

 
165,003

 
21,831

 
0.52

 
0.50

September 30, 2020
660,673

 
174,470

 
20,091

 
0.44

 
0.41

 
$
2,407,522

 
$
641,426

 
$
53,429

 
$
1.25

 
$
1.19

2019
 

 
 

 
 

 
 

 
 

December 31, 2018
$
510,522

 
$
139,780

 
$
8,753

 
$
0.21

 
$
0.21

March 31, 2019
549,633

 
133,537

 
6,490

 
0.16

 
0.15

June 30, 2019
574,970

 
151,699

 
14,128

 
0.34

 
0.33

September 30, 2019
574,164

 
158,458

 
16,251

 
0.40

 
0.37

 
$
2,209,289

 
$
583,474

 
$
45,622

 
$
1.11

 
$
1.06


 
Notes to Quarterly Financial Information (unaudited):
•
Earnings (loss) per share are computed independently for each quarter and year presented; as such the sum of the quarters may not be equal to the full year amounts.
•
2020 Net income, and the related per share earnings, included, net of tax, restructuring charges of $4,148, $3,005, $1,224 and $3,488 for the first, second, third and fourth quarters, respectively, acquisition costs of $2,321 for the second quarter, loss from debt extinguishment $5,245 and $969 for the second and third quarters, respectively, benefit from the reversal of contingent consideration related to the Kelkay acquisition of $1,403 for the fourth quarter. The fourth quarter also includes a $15 and $24 tax benefit for acquisition costs and loss from debt extinguishment, respectively.
•
2019 Net income, and the related per share earnings, included, net of tax, a benefit from the reversal of contingent consideration related to the Kelkay acquisition of $1,333 for the fourth quarter.